Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

180 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effects of topical Arnica on performance, pain and muscle damage after intense eccentric exercise.
Pumpa KL, Fallon KE, Bensoussan A, Papalia S. Pumpa KL, et al. Eur J Sport Sci. 2014;14(3):294-300. doi: 10.1080/17461391.2013.829126. Epub 2013 Aug 16. Eur J Sport Sci. 2014. PMID: 23947690 Clinical Trial.
Twenty well-trained males matched by maximal oxygen uptake (V̇O2 Max) completed a double-blind, randomised placebo-controlled trial. Topical Arnica was applied to the skin superficial to the quadriceps and gastrocnemius muscles immediately after a downhill running p …
Twenty well-trained males matched by maximal oxygen uptake (V̇O2 Max) completed a double-blind, randomised placebo-controlled trial. …
Cost-effectiveness of Acupuncture for Chronic Nonspecific Low Back Pain.
Taylor P, Pezzullo L, Grant SJ, Bensoussan A. Taylor P, et al. Pain Pract. 2014 Sep;14(7):599-606. doi: 10.1111/papr.12116. Epub 2013 Oct 21. Pain Pract. 2014. PMID: 24138020 Review.
Cost-effectiveness is a major criterion underpinning decisions in mainstream health care. Acupuncture is increasingly used in patients with chronic lower back pain (LBP), but there is a lack of evidence on cost-effectiveness. ...Acupuncture as a substitute fo …
Cost-effectiveness is a major criterion underpinning decisions in mainstream health care. Acupuncture is increasingly used in patient …
The effects of Panax notoginseng on delayed onset muscle soreness and muscle damage in well-trained males: a double blind randomised controlled trial.
Pumpa KL, Fallon KE, Bensoussan A, Papalia S. Pumpa KL, et al. Complement Ther Med. 2013 Jun;21(3):131-40. doi: 10.1016/j.ctim.2012.12.007. Epub 2013 Jan 5. Complement Ther Med. 2013. PMID: 23642942 Clinical Trial.
DESIGN: A double blind randomised placebo controlled trial. SETTING: Twenty well trained male volunteers, matched by maximum aerobic capacity were randomly assigned to consume a regime of 4000 mg of P. notoginseng capsules or an indistinguishable placebo before and …
DESIGN: A double blind randomised placebo controlled trial. SETTING: Twenty well trained male volunteers, matched by maximum aerobic …
The effects of Lyprinol(®) on delayed onset muscle soreness and muscle damage in well trained athletes: a double-blind randomised controlled trial.
Pumpa KL, Fallon KE, Bensoussan A, Papalia S. Pumpa KL, et al. Complement Ther Med. 2011 Dec;19(6):311-8. doi: 10.1016/j.ctim.2011.08.004. Epub 2011 Sep 15. Complement Ther Med. 2011. PMID: 22036523 Clinical Trial.
DESIGN: A double blind randomised placebo controlled trial. SETTING: Twenty well trained male volunteers, matched by VO(2max) were randomly assigned to consume 200mg of Lyprinol(®) or an indistinguishable placebo daily for 8 weeks prior to a downhill treadmill runni …
DESIGN: A double blind randomised placebo controlled trial. SETTING: Twenty well trained male volunteers, matched by VO(2max) were ra …
A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.
Klupp NL, Kiat H, Bensoussan A, Steiner GZ, Chang DH. Klupp NL, et al. Sci Rep. 2016 Aug 11;6:29540. doi: 10.1038/srep29540. Sci Rep. 2016. PMID: 27511742 Free PMC article. Clinical Trial.
This study aimed to evaluate the efficacy and safety of Ganoderma lucidum for the treatment of hyperglycaemia and other cardiovascular risk components of metabolic syndrome using a prospective, double-blind, randomised, placebo-controlled trial. ...The primary outcome meas …
This study aimed to evaluate the efficacy and safety of Ganoderma lucidum for the treatment of hyperglycaemia and other cardiovascular risk …
A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms.
van der Sluijs CP, Bensoussan A, Chang S, Baber R. van der Sluijs CP, et al. Menopause. 2009 Mar-Apr;16(2):336-44. doi: 10.1097/gme.0b013e3181883dc1. Menopause. 2009. PMID: 19057416 Clinical Trial.
OBJECTIVE: To evaluate the effectiveness of a formula containing Chinese herbs and Cimicifuga racemosa in alleviating vasomotor symptoms and improving quality of life. ...After a 4-week baseline period, women were randomly allocated to receive herbal (equivalent to …
OBJECTIVE: To evaluate the effectiveness of a formula containing Chinese herbs and Cimicifuga racemosa in alleviating vasomotor sympt …
Acupuncture and acupressure for pain management in labour and birth: a critical narrative review of current systematic review evidence.
Levett KM, Smith CA, Dahlen HG, Bensoussan A. Levett KM, et al. Complement Ther Med. 2014 Jun;22(3):523-40. doi: 10.1016/j.ctim.2014.03.011. Epub 2014 Apr 13. Complement Ther Med. 2014. PMID: 24906592 Review.
BACKGROUND: Reviews of maternity services highlight the need for a reduction of medical interventions for women with low risk pregnancies and births to prevent the potential cascade of interventions and their associated risks. ...It may be inappropriate to include these to …
BACKGROUND: Reviews of maternity services highlight the need for a reduction of medical interventions for women with low risk pregnan …
Chinese herbal medicine for primary dysmenorrhoea.
Zhu X, Proctor M, Bensoussan A, Smith CA, Wu E. Zhu X, et al. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005288. doi: 10.1002/14651858.CD005288.pub2. Cochrane Database Syst Rev. 2007. PMID: 17943847 Updated. Review.
BACKGROUND: Conventional treatment for primary dysmenorrhoea (PD) has a failure rate of 20% to 25% and may be contraindicated or not tolerated by some women. ...MAIN RESULTS: Thirty-nine RCTs involving a total of 3475 women were included in the review. A numb …
BACKGROUND: Conventional treatment for primary dysmenorrhoea (PD) has a failure rate of 20% to 25% and may be contraindicated or not …
Chinese herbal medicine for primary dysmenorrhoea.
Zhu X, Proctor M, Bensoussan A, Wu E, Smith CA. Zhu X, et al. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005288. doi: 10.1002/14651858.CD005288.pub3. Cochrane Database Syst Rev. 2008. PMID: 18425916 Review.
BACKGROUND: Conventional treatment for primary dysmenorrhoea has a failure rate of 20% to 25% and may be contraindicated or not tolerated by some women. ...MAIN RESULTS: Thirty-nine randomised controlled trials involving a total of 3475 women were included in the re …
BACKGROUND: Conventional treatment for primary dysmenorrhoea has a failure rate of 20% to 25% and may be contraindicated or not toler …
Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C.
Batey RG, Bensoussan A, Fan YY, Bollipo S, Hossain MA. Batey RG, et al. J Gastroenterol Hepatol. 1998 Mar;13(3):244-7. doi: 10.1111/j.1440-1746.1998.01550.x. J Gastroenterol Hepatol. 1998. PMID: 9570235 Clinical Trial.
We report a study of a Chinese herbal medicine preparation CH-100 in the management of chronic hepatitis C. Patients with documented chronic hepatitis C were randomly allocated to receive active herbal or placebo tablets (five tablets thrice daily). Patients were fo …
We report a study of a Chinese herbal medicine preparation CH-100 in the management of chronic hepatitis C. Patients with docu …
180 results
Jump to page
Feedback